REGULONIX HOLDING, INC.
Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 – a well-established and genetically validated pain target – and focusing on the signaling pathways that control this channel’s activity, the Regulonix team has isolated compounds demonstrated in animal models to be non-addictive and more effective than morphine. This unique platform helps address a global pain management therapeutics market projected to reach $83B by 2024, affecting more than 100 million Americans and 1.5 billion people globally.
REGULONIX HOLDING, INC.
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Tucson, Arizona, United States
Country:
United States
Website Url:
http://www.regulonix.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Immunome
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Desert Angels
Desert Angels investment in Seed Round - Regulonix Holding, Inc.
UAVenture Capital
UAVenture Capital investment in Seed Round - Regulonix Holding, Inc.
Official Site Inspections
http://www.regulonix.com
- Host name: ec2-3-94-41-167.compute-1.amazonaws.com
- IP address: 3.94.41.167
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Regulonix Holding, Inc."
Regulonix Holding, Inc. - Crunchbase Company Profile & Funding
Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 – a well-established and genetically …See details»
A game-changing solution - Regulonix
Regulonix was founded to address the growing opioid epidemic. Our science approaches the issue of treating pain in an entirely new way that is targeted and highly selective, resulting in non-addictive solutions.See details»
Focusing on a validated biologic pain target with a unique
Regulonix is an early-stage biotechnology company developing non-opioid therapeutics that relieve chronic pain. By indirectly targeting the well-established and genetically validated pain …See details»
Regulonix Holding, Inc. | LinkedIn
Regulonix Holding, Inc. | 109 followers on LinkedIn. Non-opioid drugs for chronic pain to attack a global health epidemic. | Regulonix is an early-stage biotechnology company developing...See details»
Regulonix Company Profile 2024: Valuation, Funding & Investors
Developer of a non-opioid therapeutic drug designed to provide relief from chronic pain. The company's drug targets the genetically validated pain target NaV1.7 sodium channel and has …See details»
Regulonix Company Profile - Office Locations, Competitors ... - Craft
Regulonix is a biotechnology company developing non-opioid drugs for chronic pain. Its technology targets genetically validated pain NaV1.7 sodium channel and focuses on the …See details»
Regulonix - VentureRadar
Website: https://www.regulonix.com/ Regulonix was founded to address the growing opioid epidemic. Our science approaches the issue of treating pain in an entirely new way that is …See details»
Regulonix Holding, Inc. - Funding, Financials, Valuation & Investors
Regulonix Holding, Inc. is funded by 2 investors. Desert Angels and UAVenture Capital are the most recent investors. Which investors participated in the most funding rounds? Regulonix is a …See details»
Regulonix Holding, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Regulonix Holding, Inc. of Tucson, AZ. Get the latest business insights from Dun & Bradstreet.See details»
News - Regulonix
Regulonix Holding, Inc., a Tucson based biotechnology start-up company focused on developing non-opioid therapeutics to relieve chronic pain, recently formed a Scientific Advisory Board …See details»
Regulonix, LLC - Tech Launch Arizona
Regulonix is developing non-opioid-based small molecule inhibitors for chronic pain reduction. These molecules indirectly regulate voltage-gated sodium Nav1.7 channel via an unique …See details»
Compound Developed at UArizona Health Sciences Provides …
Nov 9, 2021 · With the help of Tech Launch Arizona, the office of the UArizona that commercializes inventions stemming from research, the university patented the compound …See details»
Startup Regulonix pursues non-opioid pain drug that indirectly …
Nov 10, 2021 · The University of Arizona has licensed the drug, dubbed 194, to a startup called Regulonix, which was co-founded by the study’s senior author, Rajesh Khanna, Ph.D., to …See details»
Non-opioid pain therapeutics company Regulonix Raises $2
Jul 10, 2018 · Regulonix, led by experienced entrepreneur Mike Sember and University of Arizona Professor of Pharmacology, co-founder and Chief Scientific Officer Dr. Rajesh Khanna, is an …See details»
UA Health Sciences Researchers Seek to Treat Pain Caused by ...
Sep 26, 2019 · UA Health Sciences Start-up company Regulonix Receives Grant as Part of NIH “Helping to End Addiction Long-Term Initiative” (NIH Heal Initiative). Researchers at the …See details»
New Pain Medication Suzetrigine Prevents Pain Signals from …
Aug 20, 2024 · The program has been helping up-and-coming developers of sodium channel inhibitors such as Regulonix, SiteOne and Navega by validating their targets, optimizing their …See details»
Compound Developed at UArizona Health Sciences Provides …
Nov 10, 2021 · Drs. Khanna and Gokhale founded Regulonix LLC in 2016 to address the growing opioid epidemic by developing new, non-addictive ways to treat pain and commercializing …See details»
A University of Arizona Drug Discovery, When Combined with …
TUCSON, Ariz., Nov. 11, 2021 /PRNewswire/ -- Dr. Rajesh Khanna, a pain medication researcher at the University of Arizona, and founder of pain therapeutic research company Regulonix, has...See details»
Compound Designed To Reverse Pain | Technology Networks
Nov 12, 2021 · Khanna and Gokhale founded Regulonix LLC in 2016 to address the growing opioid epidemic by developing new, non-addictive ways to treat pain and commercializing …See details»